Applied Therapeutics, Inc.   Report issue

For profit Phase 3
Founded: New York NY United States (2016)

Organization Overview

First Clinical Trial
2019
NCT04117711
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Applied Therapeutics, Inc.

Active Ingredients

Drugs in Phase 3 Trials (2)

at-001 (1 trial)

at-007 (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiomyopathies (Phase 3)

Diabetic Cardiomyopathies (Phase 3)

Galactosemias (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 2